Home » Stocks » Surgalign Holdings

Surgalign Holdings, Inc. (SRGA)

Stock Price: $2.93 USD 0.04 (1.38%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 218.58M
Revenue (ttm) 312.09M
Net Income (ttm) -220.42M
Shares Out 74.60M
EPS (ttm) n/a
PE Ratio n/a
Forward PE 526.32
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $2.93
Previous Close $2.89
Change ($) 0.04
Change (%) 1.38%
Day's Open 2.76
Day's Range 2.76 - 2.99
Day's Volume 503,242
52-Week Range 1.46 - 5.40

More Stats

Market Cap 218.58M
Enterprise Value 387.70M
Earnings Date (est) Aug 7, 2020
Ex-Dividend Date n/a
Shares Outstanding 74.60M
Float 55.54M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.35M
Short Ratio 2.53
Short % of Float 1.88%
Beta 2.14
PE Ratio n/a
Forward PE 526.32
P/FCF Ratio n/a
PS Ratio 0.70
PB Ratio 12.93
Revenue 312.09M
Operating Income -192.31M
Net Income -220.42M
Free Cash Flow -3.29M
Net Cash -169.12M
Net Cash / Share -2.27
Gross Margin 55.98%
Operating Margin -61.62%
Profit Margin -70.60%
FCF Margin -1.05%
ROA -0.88%
ROE -113.98%
ROIC -60.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$5.50*
(87.71% upside)
Low
5.00
Current: $2.93
High
6.00
Target: 5.50
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue308280280276282263198178169166
Revenue Growth9.99%0%1.58%-2.23%7.41%32.75%11.15%5.2%1.89%-
Gross Profit17114014313315013480.1185.2277.2176.00
Operating Income-182-4.31-4.75-15.2624.635.63-28.6612.2411.77-127
Net Income-212-3.126.91-13.8114.922.70-17.818.408.38-129
Shares Outstanding72.8263.5259.6858.2457.6156.7456.2655.8655.1554.73
Earnings Per Share-2.91-0.080.05-0.300.20-0.01-0.340.150.15-2.36
EPS Growth-------0%--
Operating Cash Flow-9.4617.255.7915.329.006.89-4.4520.8027.7729.39
Capital Expenditures-14.43-11.04-10.48-15.34-17.74-15.58-15.01-11.09-6.35-3.24
Free Cash Flow-23.886.21-4.70-0.01-8.74-8.68-19.479.7121.4226.15
Cash & Equivalents5.6110.9522.3813.8512.6115.7018.7249.7046.1828.21
Total Debt17449.0746.3483.3579.2475.8969.050.120.593.00
Net Cash / Debt-169-38.12-23.96-69.50-66.62-60.19-50.3349.5845.5925.22
Assets345360346368381378370241230226
Liabilities24411210014314315715257.4257.6163.82
Book Value34.56182182165181168168184172162
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Surgalign Holdings, Inc.
Country United States
Employees 935
CEO Terry M. Rich

Stock Information

Ticker Symbol SRGA
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: SRGA
IPO Date August 10, 0200

Description

Surgalign Holdings, Inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.